Navigation Links
Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder
Date:5/26/2010

>

To the extent any statements made in this release contain information that is not historical, these statements are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and may be forward-looking information under applicable Canadian provincial securities legislation (collectively, "forward-looking statements").  These forward-looking statements relate to, among other things, objectives, goals, targets, strategies, intentions, plans, beliefs, estimates and outlook, and can generally be identified by the use of words such as "believe," "anticipate," "expect," "intend," "plan," "will," "may", "potential" and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements.

Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs.  Forward-looking statements also involve assumptions that, if they prove incorrect, would cause results to differ materially from those expressed or implied by such forward-looking statements.  Although Alexza and Biovail believe that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements.  Certain material factors or assumptions are applied in making forward-looking statements, including, but not limited to, factors and assumptions regarding the reliability of research findings, and actual results may differ materially from those expressed or implied in such statements.  Important factors that could cause actual results to differ materially from these expectations include, among other things:
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.; Biovail Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
2. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
3. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
4. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
5. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
6. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
7. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
8. Alexzas AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients
9. Alexzas AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial
10. Alexza Initiates AZ-104 (Staccato(R) Loxapine) Phase 2b Clinical Trial in Patients With Migraine Headaches
11. Alexza Announces Preliminary Results from its AZ-104 (Staccato(R) Loxapine) Phase 2b Trial in Patients with Migraine Headache
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 2015  PDL BioPharma, Inc. (NASDAQ: PDLI ) ... agreement with CareView Communications, Inc. (OTCQB: CRVW) whereby PDL ... secured debt financing. CareView is an information technology provider ... Under the credit agreement, PDL will provide ... in two tranches of $20 million, based upon the ...
(Date:6/29/2015)... , June 29, 2015  Allergan plc ... intends to release second quarter 2015 financial results ... open of the U.S. financial markets. The Company will ... a.m. Eastern Daylight Time on Thursday, August 6, ... to access the call is U.S./ Canada ...
(Date:6/29/2015)... TARRYTOWN, N.Y. , June 29, 2015 /PRNewswire/ ... today announced that the Proceedings of the ... a paper demonstrating that the Company,s proprietary VelociGene ... the rapid identification and preclinical validation of potential ... and treatment of Middle East Respiratory Syndrome (MERS). ...
Breaking Medicine Technology:PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 2PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 4Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 2Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 2Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 4Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 5
... DURHAM, N.C., May 1, 2012 Heart IT, ... approved zero footprint medical imaging workstation, WebPAX®, announced ... "zero-footprint" medical image viewing technologies. "Zero-footprint" technologies allow ... any computing platform with a standard Internet web ...
... 2012 Amarantus BioSciences, Inc. (OTCBB: AMBS), a ... the treatment of Parkinson,s disease and other nervous ... selected to present in the Emerging Companies Showcase ... Meeting on May 2nd, 2012 in New York ...
Cached Medicine Technology:U.S. Patent Office Issues Sixth Patent Covering 'Zero-Footprint' Medical Image Viewers to Heart Imaging Technologies, LLC 2Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012 2Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012 3
(Date:6/30/2015)... ... 2015 , ... Intellitec Solutions has announced they will be hosting two webinars ... enhanced changes and new procedures involved with updating the cloud version of Dynamics CRM, ... the new user interface and what it will mean for end users, critical items ...
(Date:6/30/2015)... ... June 30, 2015 , ... Healthy ... enhance successful student outcomes. According to Dr. Theo Wubbels (Professor of Education, ... must be able to show “all kinds of behavior when the situation asks ...
(Date:6/30/2015)... ... June 30, 2015 , ... Medflow, the ... a SaaS electronic health records system from the company exclusively dedicated to helping ... 2.0 delivers an intuitive state-of-the-art solution combining modern cloud technology with Medflow’s proven ...
(Date:6/30/2015)... ... 2015 , ... This Fourth of July, Peacock Alley celebrates the ... work, tenacity, perseverance, commitment to quality, honesty and love of friends and family. These ... Gabler's simple love of quilts, Peacock Alley was fully realized and grown while raising ...
(Date:6/30/2015)... , ... June 30, 2015 , ... Curly Hair Solutions™ ... the largest beauty event in the US, featuring products from all over the world. ... Collection. The Collection is a line of hair styling products focused entirely on meeting ...
Breaking Medicine News(10 mins):Health News:Intellitec Solutions to Host Microsoft CRM 2015 Update Webinar 2Health News:Lessons On Leadership - Top 12 Global Teacher Bloggers Reveal the Best Strategies for Building Positive Leadership in Global Classrooms 2Health News:Medflow Launches MEDFLOW 2.0 EHR – The Cloud-Based Ophthalmology EHR 2Health News:Luxury Linen Purveyor Peacock Alley Celebrates the Fourth of July 2Health News:Curly Hair Solutions™ Showcases Entire Curl Keeper™ Collection at Cosmoprof Las Vegas July 12 - 14 2
... , , BURLINGTON, Mass., ... expansion to its product offering with the delivery of ... the integration of the ClearPoint Security Performance Manager (TM) ... The ClearPoint Unified Security Performance and Compliance Manager. The ...
... , , , Flexible ... , NEW YORK, Sept. 14 The American ... Parkinson Foundation (NPF) Young Onset Parkinson Network are co-sponsoring a series ... caregivers. The first conference will be held in Dallas, Texas ...
... ... Snoring and obstructive sleep apnea are serious medical problems. Obstructive sleep ... serious illnesses. Increasingly, specially trained dentists are being called upon to provide ... to wear a CPAP unit. Choosing a sleep-disorders dentist who is qualified ...
... , , , PITTSBURGH, Sept. ... Inc. is prototyping an innovative stroke treatment device designed to speed ... , , Michele Migliuolo, NeuroInterventions President ... a presentation at the 3 Rivers Venture Fair in Pittsburgh on ...
... , WASHINGTON, Sept. 13 Bread for ... citing him as an outstanding individual who has done more to save ... , , "No single person has contributed more ... Rev. David Beckmann, president, Bread for the World. "Norman was truly the ...
... , NAPA, Calif., Sept. 11 Dey L.P., ... today issued an advisory regarding the theft of two different ... and Albuterol Sulfate Inhalation Solution, 0.083%, unit-dose vials. The lots ... of Florida. , , The NDC ...
Cached Medicine News:Health News:ClearPoint Announces Metric Applications Packages for PCI DSS, NERC, Healthcare Compliance and FISMA 2Health News:ClearPoint Announces Metric Applications Packages for PCI DSS, NERC, Healthcare Compliance and FISMA 3Health News:ClearPoint Announces Metric Applications Packages for PCI DSS, NERC, Healthcare Compliance and FISMA 4Health News:APDA/NPF Young Onset Parkinson's Conference Series Kick-Off in Dallas, October 23-24 2Health News:APDA/NPF Young Onset Parkinson's Conference Series Kick-Off in Dallas, October 23-24 3Health News:Snoring Isn't Sexy, LLC Proposes 7 Patient Guidelines for Selecting a Sleep Medicine Dentist 2Health News:Snoring Isn't Sexy, LLC Proposes 7 Patient Guidelines for Selecting a Sleep Medicine Dentist 3Health News:Snoring Isn't Sexy, LLC Proposes 7 Patient Guidelines for Selecting a Sleep Medicine Dentist 4Health News:Rapid-response Technology from NeuroInterventions, Inc. Aims to Quickly Restore Brain's Blood Flow After a Stroke 2Health News:Bread for the World Mourns Passing of Norman Borlaug 2Health News:Dey Issues Advisory 2
... gloves, Polymed has become even better. Polymed® TLC ... regular Polymed with the exciting addition of vitamin ... antioxidants, which are vital to healthy skin. Polymed ... to reduce the potential for latex sensitization. The ...
CYSTOSCOPY "T". DRAPE...
... for use in urology and gynecology. ... fluid strike-through, and help eliminate the need ... saving time and money (1071). 23 inch ... Drape, Clear plastic, Adhesive strip, Circle aperture, ...
... Both the Penilab IV and the Penilab V have ... Model 1060 is similar to the Model 1061 ... can one be added later. The Penilab V ... all of the accessories you'll need to get started. ...
Medicine Products: